SALVADOR TERRONES: Open Payments
NPI 1619183209 · MONTEBELLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,740 in 67 payments from 17 companies in 2025. Trend: 2023 $3,436 · 2024 $4,622 · 2025 $3,740
Food & beverage: $3,740
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $816 |
| Amgen Inc. | 15 | $750 |
| Madrigal Pharmaceuticals | 7 | $479 |
| GENZYME CORPORATION | 6 | $319 |
| Regeneron Healthcare Solutions, Inc. | 5 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $242 |
| AstraZeneca Pharmaceuticals LP | 2 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $202 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
Products named: DUPIXENT, Wegovy, REZDIFFRA, REPATHA, OTEZLA, Ozempic, CAPLYTA, Kerendia.
Industry payments across CA — which companies pay providers there.
